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Abstract Azotobacter vinelandii UW97 is defective in nitrogen
fixation due to a replacement of serine at position 44 by
phenylalanine in the Fe-protein [Pulakat, L., Hausman, B.S.,
Lei, S. and Gavini, N. (1996) J. Biol. Chem. 271, 1884^1889].
Serine residue 44 is located in a conserved domain that links the
nucleotide binding site and the MoFe-protein docking surface of
the Fe-protein. Therefore, it is possible that the loss of function
by A. vinelandii UW97-Fe-protein may be caused by global
conformational disruption or disruption of the conformational
change upon MgATP binding. To determine whether it is
possible to generate a functional nitrogenase complex via a
compensating second site mutation(s) in the Fe-protein, we have
attempted to isolate genetic revertants of A. vinelandii UW97
that can grow on nitrogen-free medium. One such revertant,
designated A vinelandii BG9, encoded a Fe-protein that retained
the Ser44Phe mutation and also had a second mutation that
caused the replacement of a lysine at position 170 by glutamic
acid. Lysine 170 is highly conserved and is located in a conserved
region of the Fe-protein. This region is implicated in stabilizing
the MgATP-induced conformation of the Fe-protein and in
docking to the MoFe-protein. Further complementation analysis
showed that the Fe-protein mutant that retained serine 44 but
contained the substitution of lysine at position 170 by glutamic
acid was also non-functional. Thus, neither Ser44Phe nor
Lys170Glu mutants of Fe-protein were functional; however, the
Fe-protein in A. vinelandii BG9 that contained both substitutions
could support diazotrophic growth on the strain. ß 2000 Fed-
eration of European Biochemical Societies. Published by Else-
vier Science B.V. All rights reserved.
Key words: nifH ; Nitrogenase; Fe-protein;
Second site mutation; Azotobacter
1. Introduction
The enzyme nitrogenase catalyzes the MgATP-dependent
reduction of N2 to ammonia. It is composed of two separately
puri¢ed proteins, the Fe-protein and the MoFe-protein, en-
coded by nifH and nifDK genes, respectively [1,2]. The Fe-
protein is a homodimer of 60 kDa in size containing a single
[4Fe^4S] center, while the MoFe-protein is an K2L2 tetramer
of 240 kDa in size containing two pairs of metal centers, the
P-clusters and FeMo-cofactors [3^8]. The Fe-protein functions
as an electron donor to the MoFe-protein. This electron trans-
fer is thermodynamically unfavorable and requires the hydro-
lysis of 2MgATP per electron transferred [9^13]. Apart from
the critical role that the Fe-protein plays in electron transfer
to the MoFe-protein in a MgATP-dependent reaction, the Fe-
protein also has at least two additional functions. Firstly, it is
involved in the initial biosynthesis of FeMo-cofactor [14^16].
Although details of the actual pathway for FeMo-cofactor
biosynthesis have not yet been established, it has been docu-
mented that the FeMo-cofactor is synthesized separately from
the MoFe-protein polypeptides [17,18]. At least seven nif
genes ^ nifB, nifE, nifH nifN, nifQ, nifV and nifX ^ are known
to be involved in this process [19^22]. The ¢rst evidence of the
involvement of nifH in cofactor biosynthesis came from the
observation that the mutant Azotobacter vinelandii DJ54,
which does not synthesize the nifH polypeptide, does not syn-
thesize the FeMo-cofactor [15]. Puri¢cation of the FeMo-co-
factor-de¢cient MoFe-protein from this strain and its subse-
quent characterization by biochemical and spectroscopic
analysis further con¢rmed the speculated role of NifH in co-
factor biosynthesis [14]. Secondly, the Fe-protein’s function
also involves its participation in the maturation of an inactive
FeMo-cofactor-de¢cient MoFe-protein [16,23,24]. Recently it
was shown that assembly of the active MoFe-holoprotein re-
quires MgATP and apodinitrogenase reductase (the Fe-pro-
tein without the [4Fe^4S] cluster) [25]. Even though the bind-
ing of MgATP to the apodinitrogenase reductase is required,
MgATP hydrolysis is not needed for its ability to participate
in the assembly and maturation of the MoFe-holoprotein
[23,26].
Upon MgATP binding, ¢ve regions of the Fe-protein
undergo detectable conformational changes [27,28]. Those re-
gions are involved in nucleotide binding, ligating the [4Fe^4S]
cluster, and forming the MoFe-protein docking surface of Fe-
protein. Any change causing conformation disruption could
cause the loss of the Fe-protein function by impairing
MgATP-induced conformational changes, MgATP hydrolysis,
complex formation, or complex dissociation [12,23,29^39].
However, the mutation of amino acids that are not located
in the regions that are thought to be important to the con-
formational integrity of the Fe-protein functions could also
result in a non-functional Fe-proteins [31,38]. Those residues
are most likely associated with the regions involved in ATP
hydrolysis or transducing the signal from nucleotide binding
site to either the [4Fe^4S] cluster or the MoFe-protein dock-
ing site. As reported earlier, the A. vinelandii UW97 Fe-pro-
tein (Ser44Phe) lost its function in both FeMo-cofactor bio-
synthesis/insertion and electron transfer to the MoFe-protein
[33,40]. Serine 44 is located in a peptide chain which links the
nucleotide binding site and the MoFe-protein docking surface
of the Fe-protein [4,27]. It has also been suggested that this
region may participate in the MgATP-induced conformational
changes of the Fe-protein, MgATP hydrolysis, and the disso-
ciation of the Fe-protein-MoFe-protein complex [4,31]. How-
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ever, this region (Gly-37 through Thr-45) does not undergo
dramatic conformational changes upon MgATP binding [27],
indicating that the loss of function by Ser44Phe^Fe-protein
may be caused by global conformational disruption or by
the disruption of the conformational change upon MgATP
binding. Therefore, mutations either at the docking surface
of the Fe-protein or the docking sites of the MoFe-protein
to ¢t Ser44Phe^Fe-protein could result in a functional nitro-
genase complex. To isolate genetic revertants of A. vinelandii
UW97 that can grow on nitrogen-free medium, cells were
grown for several generations on BN medium at 30‡C and
then plated on Nif3 agar medium to score for forced rever-
tants with the diazotrophic phenotype. This procedure re-
sulted in the isolation of a revertant which exhibited a Nif
phenotype and showed diazotrophic growth similar to that of
the A. vinelandii OP strain (Fig. 1). This strain was designated
A. vinelandii BG9 (Table 1).
2. Materials and methods
2.1. Bacterial strains and growth conditions
The bacterial strains and plasmids used in this study are listed in
Table 1. The Escherichia coli strains were grown at 37‡C in Luria
broth or 2YT [41]. The ampicillin and tetracycline were used to a
¢nal concentration of 50 Wg/ml and 20 Wg/ml respectively wherever
the selection was made. A. vinelandii strains were grown at 30‡C in
modi¢ed Burk’s nitrogen-free (BN3) medium [42]. When it was nec-
essary to include ¢xed nitrogen in the medium, ammonium acetate
(NH4OAcWH2O) was added to a ¢nal concentration of 400 Wg/ml.
2.2. Isolation of genetic revertant of A. vinelandii UW97
A. vinelandii UW97 was grown in 5 ml of BN liquid medium until
its OD600 reached about 0.4^0.6. The cells were harvested by centri-
fugation at 4000 rpm, for 5 min. The cell pellets were washed three
times by resuspending in 5 ml of BN3 medium to remove traces of
ammonia, and collecting the cells by centrifugation. At the last step
the cells were resuspended in 1 ml of BN3 medium and about 0.2 ml
of this cell suspension was plated on BN3 plates. The colonies were
allowed to grow at 30‡C. After 4 days of incubation, single colonies
corresponding to spontaneous revertants appeared on nitrogen-free
agar plates. One of these revertant colonies designated A. vinelandii
BG9 (Table 1) was subjected to further analysis.
2.3. Construction of nifHp^lacZ in A. vinelandii BG9
To generate a nifHp^lacZ mutation on A. vinelandii BG9 chromo-
some, a Tn5-B21 mutagenesis was employed by a modi¢ed method
described by Joerger et al. [43]. The plasmid pBG507 (Table 1) was
introduced into E. coli strain (supE3) and colonies carrying this plas-
mid were infected with V :Tn5-B21 phage suspension as described
previously [43]. The mixture was incubated for 2 h at 37‡C. The
infected cells were plated onto LB plate containing tetracycline (20
Wg/ml) and allowed to grow for 24 h. Tetr cells were pooled and
plasmid DNA was isolated. The plasmid DNA carrying Tn5-B21 in
nifHp was designated pBG510. This plasmid was used to deliver
nifHp:lacZ fusion onto the chromosome of A. vinelandii BG9 as de-
scribed below.
2.4. General molecular biology techniques
PCR ampli¢cations [44], DNA sub-cloning, plasmid DNA isola-
tions, restriction enzyme digestions, agarose gel electrophoresis, liga-
tions and E. coli transformations were carried out as described in the
laboratory manuals [41] or as suggested in the manufacturers instruc-
tions. The puri¢ed PCR products were either used to transform A.
vinelandii strains or cloned into pCR1 vector for DNA sequence
analysis. Restriction enzymes were purchased either from Boehringer
Mannheim (Indianapolis, IN, USA) or from Promega (Madison, WI,
USA). Oligonucleotides used for PCR ampli¢cation were purchased
from Gibco BRL Life Technologies Inc. (Gaithersburg, MD, USA).
Radiolabeled material for sequencing ([35S]dATP) was obtained from
Dupont NEN (Boston, MA, USA). The nucleotide sequencing was
performed using T7 sequencing kit purchased from USB-Amersham
Inc. (Cleveland, OH, USA).
2.5. Construction of A. vinelandii mutant strains
To construct A. vinelandii strains that contained site-directed muta-
tions in the nifH gene, a gene replacement technique previously de-
scribed in detail was used [45,46]. A. vinelandii strains have a very
e⁄cient recombination system that allows homologous recombination
between the newly delivered sequence and the host chromosome. The
plasmids used in the study are derivatives of pUC18 and pCR2.1
carrying the mutated version of the nifH gene. These non-replicative
plasmids were used to transform A. vinelandii and the transformants
were selected on BN3 agar where ever the selection was made for N2
¢xation pro¢cient strains.
3. Results and discussion
3.1. Localization and identi¢cation of a second site mutation in
the Fe-protein (Ser44Phe) that restored the wild type
Fe-protein function in A. vinelandii BG9
The A. vinelandii BG9 could acquire the Nif phenotype by
several di¡erent types of mutations. It may be that the muta-
tion that is responsible for the Nif phenotype of this strain is
a simple replacement of phenylalanine at position 44 back to
serine as in the wild type [33], another complementing substi-
tution (unpublished data) or a second mutation located at a
di¡erent position in the Fe-protein or in one of the subunits of
the MoFe-protein. It is also possible that the second mutation
is located in one of the accessory proteins of the nif-system
[47] and has resulted in the modi¢cation of the functions of
that accessory protein; or that it is located in the structural or
accessory genes of the vnf- or anf-system [48] and has resulted
in the activation of that system in the presence of molybde-
num. Therefore, our ¢rst task was to determine if the muta-
tion responsible for the Nif phenotype of A. vinelandii BG9
was located in the nif-system or in one of the other two alter-
native systems. To do this we constructed a plasmid desig-
nated pBG510 in which the nif-structural genes were disrupted
by insertion of lacZ-Tet cartridge [43] on the nifH gene. This
was done by subjecting the nifH gene present on the plasmid
Fig. 1. Growth characteristics of A. vinelandii strains in BN3 me-
dium. An overnight culture was prepared by inoculating freshly
growing colonies from agar plates into Burk’s medium supple-
mented with ammonium acetate. Cells from the overnight culture
were collected and washed with BN3 medium and then transferred
to side-arm £asks that contained the same medium. Cell densities
were recorded over 32 h time periods. This analysis showed that the
A. vinelandii BG9 strain has similar growth characteristics as that of
the A. vinelandii OP.
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pUC18 to Tn5-B21 mutagenesis [43] to integrate the lacZ-Tet
cartridge on the coding sequence of the nifH. The plasmid
DNA samples isolated from tetracycline-resistant E. coli col-
onies were subjected to restriction enzyme analysis to localize
the position of lacZ-Tet cartridge integration. The plasmid
that carried the lacZ-Tet cartridge in the coding sequence of
the nifH isolated by this procedure was designated pBG510.
A. vinelandii BG9 was transformed with this plasmid and the
transformants were selected on BN agar medium supple-
mented with tetracycline. Since the plasmid pBG510 has a
colE1 origin of replication which does not support replication
in A. vinelandii cells, we could obtain Tetr transformants by
the integration of the lacZ-Tet cartridge into the nifH by
double point, reciprocal recombination. Since the structural
genes of the nif-system ^ nifH, nifD and nifK ^ are continuous
and constitute a single operon on the A. vinelandii chromo-
some [3,47], disruption of the nifH gene by integration of the
lacZ-Tet cartridge can also disrupt the expression of the nifD
and nifK. If the compensating mutation(s) is (are) in any of
nif-structural genes, the integration of lacZ-Tet cartridge
should disrupt the synthesis of functional nitrogenase. We
observed that all the Tetr transformants of A. vinelandii
BG9 were also Nif3 suggesting that the second mutation
was located in the nif-system. Therefore, the diazotrophic
growth observed in A. vinelandii BG9 is due to the expression
of the nif-system and not the activation of the vnf- or anf-
system. To further determine whether any mutations had oc-
curred in the promoter region that may have resulted in ele-
vated expression of the nif-structural genes, the L-galactosi-
dase activity of the A. vinelandii BG9 was determined under
repressed and derepressed conditions. Since the lacZ gene is
under the transcriptional control of nifH promoter, the L-ga-
lactosidase activity of the A. vinelandii BG9 was taken as a
measure of the nifHDK promoter activity. The L-galactosidase
activity of A. vinelandii BG9 observed under repressed and
derepressed conditions was comparable to the L-galactosidase
activity detected from unaltered nifHp under similar growth
conditions. These results suggest that no mutations resulting
in an elevated level of expression of the nif-structural genes
have occurred in A. vinelandii BG9.
To determine which of the nif-structural genes of A. vine-
landii BG9 carried the compensating mutation responsible for
Nif phenotype, we PCR-ampli¢ed [44] the DNA fragments
corresponding to the coding sequence of the nifH, nifD and
nifK genes using appropriate primers and the chromosome of
A. vinelandii BG9. The primers used for PCR amplifying the
nifH were 5P-GATATCATGCGTCAATGCGCCATCTAC-
GGC-3P and 5P-GGATCCT CAGACTTCGGCGGTTTTG-
CCGACGATGG-3P ; for nifD were 5P-GACCGGTATGTCG
CGCGAAGAGGTTGAAT-3P and 5P-TCAGGCGCTGGC-
GGCGACTTTCTCGGCGCCTT-3P ; and for nifK were 5P-
GAGCCAGCAAGTCGATAAAATCAAAGCCAG-3P and
5P-AGCGTACCA GGTCGTGGTTGTAGTCGGT-3P. The
DNA fragments encoding the nifH, nifD or nifK from A.
vinelandii BG9 (generated by PCR ampli¢cation) were used
to transform the A. vinelandii UW97 [45,46]. Since the DNA
fragments encoding the nif-structural genes share homology
with the chromosome it was expected that they would under-
go recombination with their counterparts present on the chro-
mosome [46]. If any of these DNA fragments carried the
complementing mutation of A. vinelandii BG9 responsible
for Nif phenotype, that fragment will be able to complement
Fig. 2. Genetic map of the nifH gene and observed phenotype of A.
vinelandii mutant strains are shown. The strains carrying single mu-
tations (Ser44Phe, Lys170Glu) are Nif3 whereas the strain carrying
both mutations was able to show Nif phenotype.
Table 1
Bacterial strains and plasmids used in this study
Strain or plasmid Relevant characteristics and description Source or reference
E. coli TG1 K12, v(lac-pro), supE, thi-1, lacIq, lacZvM15, hsdD5 [FP traD36 proAB] Amersham life
sciences Inc. IL,
USA
E. coli HB101 F3 supE44 thi-1 hsdS20 (rB-, mB-) proA2 ara14 galK lacY1 rspL20 (Strr) xyl-5 mtl-1 recA
13 mcrB leuB6
Invitrogen,
Carlsbad, CA, USA.
A. vinelandii OP Wild type, Nif, soil bacterium. Laboratory stock
A. vinelandii DJ54 Nif3 ; de¢ned deletion in the nifH gene. [14,15]
A. vinelandii UW97 Nif3 ; isolated by following nitrosoguanidine mutagenesis. The speci¢c mutation responsible
for the Nif3 phenotype is the substitution of a non-conserved serine at position 44 of the
Fe-protein by phenylalanine.
[33,40]
A. vinelandii BG9 Nif ; Spontaneous revertant of A. vinelandii UW97; this strain contained a functional
A. vinelandii UW97-derived Fe-protein
This work
pCR02.1 AmprKanr ; 3.9 kb used for cloning PCR products Invitrogen,
Carlsbad, CA, USA.
pBG507 Derivative of pCR02.1 in which a 940 bp DNA fragment that encodes the NifH open reading
frame from A. vinelandii BG9 was cloned. This fragment was generated by PCR ampli¢cation
using the primers complementary to the DNA immediately outside of NifH coding sequence.
This work
pBG508 Derivative of pCR02.1 in which a 940 bp DNA fragment that encodes the NifH open reading
frame was cloned. The NifH open reading frame contained serine at position 44, which is same
as in the wild type NifH and at position 170 a substitution of glutamic acid to replace lysine.
This work
pBG510 Derivative of pUC18 in which a 940 bp DNA fragment that encodes the NifH open reading
frame was cloned. Then the NifH open reading frame was subjected to Tn5 mutagenesis to
generate this plasmid that contained nifH: :lacZ-Tet.
This work
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the defect present in the nitrogenase of A. vinelandii UW97.
Our results showed that the A. vinelandii UW97 cells trans-
formed with the DNA fragment carrying the nifH coding se-
quence of A. vinelandii BG9 became Nif (Fig. 2). On the
other hand, the A. vinelandii UW97 cells transformed with
DNA fragments that carried the nifD or nifK coding sequen-
ces of A. vinelandii BG9 remained Nif3. These results sug-
gested that the complementing mutation of A. vinelandii
BG9 responsible for its Nif phenotype is located in the
nifH coding sequence.
To identify the exact location of the complementing muta-
tion that rendered the A. vinelandii BG9 the Nif phenotype,
we cloned the DNA fragment carrying the nifH coding se-
quence of the A. vinelandii BG9 into pCR12-1 (Table 1)
and subjected it to nucleotide sequence analysis. This analysis
showed that the original mutation, Ser44Phe, present in the
Fe-protein of A. vinelandii UW97 was unaltered in Fe-protein
of A. vinelandii BG9. Interestingly, we found another change
in the A. vinelandii BG9 nifH coding sequence (Fig. 2). This
second mutation was located at position 170 where a lysine
codon (AAG) was replaced by a codon for glutamic acid
(GAG). Therefore, substitution of lysine 170 by glutamic
acid resulted in generating a functional UW97-derived Fe-pro-
tein. Thus it seems that in the A. vinelandii BG9 Fe-protein
the defect due to Ser44Phe mutation was nulli¢ed by the sec-
ond site mutation Lys170Glu.
To identify the contribution of the Lys170Glu which cor-
rected the dysfunction caused by Ser44Phe mutation, we en-
gineered a nifH gene that contained only the Lys170Glu mu-
tation and this plasmid was designated pBG508. A. vinelandii
UW97 and A. vinelandii DJ54 (Table 1) were transformed
with pBG508 and the transformants were analyzed for an
acquired Nif phenotype. It was found that the pBG508
could not provide A. vinelandii UW97 or A. vinelandii DJ54
transformants with Nif phenotype. The Ser44Phe mutation
of Fe-protein resulted in a non-functional Fe-protein [33] ; and
the Lys170Glu mutation of the Fe-protein also resulted in a
non-functional Fe-protein (Fig. 2). Taken together, these re-
sults indicated that the Ser44Phe and Lys170Glu double mu-
tation in the nifH gene generated a new functional Fe-protein,
although single mutations produced non-functional Fe-pro-
teins.
3.2. Conclusions
Extensive mutational analysis combined with biochemical
and spectroscopic methods has helped to determine the struc-
ture^function relationship of some of the conserved amino
acid clusters in the Fe-protein [1,26]. From the crystal struc-
ture it is predicted that in the A. vinelandii Fe-protein func-
tional salt bridges may form between Lys-15 and Asp-125.
Substituting glutamine or proline for Lys-15 has shown that
this lysine appears to be essential for the MgATP-induced
conformational change of the wild type Fe-protein. Replacing
Asp-125 with either glutamate (which has a similar charge) or
with asparagine resulted in a Nif3 phenotype, caused by its
inability to undergo the MgATP-induced conformational
change [39]. Another amino acid that is essential for the
MgATP-induced conformational change of the wild type Fe-
protein is alanine at position 157 [23,49].
Serine 44 and other residues of the conserved second do-
main are located at the core of the Fe-protein and around the
MgATP binding site (Fig. 3). Asp-39 and Asp-43 are impli-
cated in playing a role in the hydrolysis of MgATP. Ser-44 lies
in between Lys-15 and Asp-125 (Fig. 3); therefore, the re-
placement of serine by phenylalanine would introduce a hy-
drophobic ring instead of the hydroxyl group at the side chain
and might distort or even disrupt the salt bridge between Lys-
15 and Asp-125. In addition, the side chain of Ser-44 is likely
Fig. 3. A model showing the position of lysine 170 of Fe-protein based on the published structure of the complex between the Fe- and MoFe-
proteins stabilized by MgADPWAlF34 . The lysine 170 which is changed to glutamic acid in the A. vinelandii BG9 strain is located very close to
Asn-173 which interacts with lysine 171 of the L subunit of MoFe-protein. The serine 44 which was changed to phenylalanine in the Fe-protein
of A. vinelandii UW97 strain is also marked.
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to hydrogen bond to the nucleotide [4,39]; therefore, the sub-
stitution of serine at position 44 by phenylalanine may dis-
place the nucleotide and cause other conformational shifts.
Combining these e¡ects, it can be assumed that the mutation
Ser44Phe disrupts the structural rearrangement upon MgATP
binding which is required for the docking of the Fe-protein
onto the MoFe-protein. On the other hand, the highly con-
served lysine 170 is located in the region of Cys-151 to Ser-
176, which overlaps the highly conserved ¢fth domain of the
Fe-protein (Fig. 3). The Met-156 located in this region of the
Fe-protein, is suggested to be involved in interacting with
Asp-43 and the nucleotide in the other subunit. Replacing
this residue with cysteine induced an altered, non-productive
conformational change to the Fe-protein when MgATP was
bound [30]. Similarly, Ala157Ser^Fe-protein also was unable
to undergo MgATP-induced conformational change [23,49]. It
was also suggested that Ala-157 is involved in stabilizing ini-
tial conformational changes of helix K5 in the Fe-protein
upon Mg-ATP binding [29]. Thus it seems that amino acids
in this domain are essential for stabilizing the Mg-ATP in-
duced conformational changes. Moreover, Lys-170 is very
close to Asn-173 which interacts with Lys-171 of the L subunit
of MoFe-protein in the nitrogenase complex (Fig. 3). The
change from lysine to glutamic acid at position 170 would
produce a much stronger interaction between Lys-171 of the
L subunit of the MoFe-protein and Glu-170 and Asn-173
residues from the Fe-protein. This interaction or the local
conformational changes caused by the substitution of lysine
170 by glutamic acid could let the Fe-protein and the MoFe-
protein form a functional complex.
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